UCLA researchers have received a federal grant worth up to $7 million over five years to launch a clinical trial examining whether drugs used to treat autoimmune diseases can prevent or reverse a rare form of diabetes caused by cancer immunotherapy, UCLA announced Tuesday. The grant from the National Institute of Allergy and Infectious Diseases, […]